Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Retigabine 200mg tablets
0408010AJAAABAB
|
Retigabine | Retigabine | Central Nervous System | No data available |
|
Retigabine 300mg tablets
0408010AJAAACAC
|
Retigabine | Retigabine | Central Nervous System | No data available |
|
Retigabine 400mg tablets
0408010AJAAADAD
|
Retigabine | Retigabine | Central Nervous System | No data available |
|
Retigabine 50mg tablets
0408010AJAAAEAE
|
Retigabine | Retigabine | Central Nervous System | No data available |
|
Retigabine 50mg tablets and Retigabine 100mg tablets
0408010AJAAAFAF
|
Retigabine | Retigabine | Central Nervous System | No data available |
|
Retin-A 0.01% gel
1306010V0BBADAL
|
Retin-A | Tretinoin | Skin | No data available |
|
Retin-A 0.025% cream
1306010V0BBAEAE
|
Retin-A | Tretinoin | Skin | No data available |
|
Retin-A 0.025% gel
1306010V0BBABAM
|
Retin-A | Tretinoin | Skin | No data available |
|
Retin-A 0.025% lotion
1306010V0BBACAC
|
Retin-A | Tretinoin | Skin | No data available |
|
Retinol 150,000units/ml oral drops
0906011D0AAAXAX
|
Vitamin A | Vitamin A | Nutrition and Blood | No data available |
|
Retinova 0.05% cream
1308010V0BBAAAA
|
Retinova | Tretinoin | Skin | No data available |
|
Retrovir 100mg capsules
0503010Y0BBAAAA
|
Retrovir | Zidovudine | Infections | No data available |
|
Retrovir 100mg/10ml oral solution
0503010Y0BBAEAD
|
Retrovir | Zidovudine | Infections | No data available |
|
Retrovir 250mg capsules
0503010Y0BBABAB
|
Retrovir | Zidovudine | Infections | No data available |
|
Retrovir IV 200mg/20ml concentrate for inf vials
0503010Y0BBAFAE
|
Retrovir | Zidovudine | Infections | No data available |
|
Revatio 10mg/12.5ml solution for injection vials
0205010Y0BBACAC
|
Revatio | Sildenafil(Vasodilator Antihypertensive) | Cardiovascular System | No data available |
|
Reviparin sodium 1,432units/0.25ml inj pre-filled syringes
0208010AAAAAAAA
|
Reviparin sodium | Reviparin sodium | Cardiovascular System | No data available |
|
Revlimid 15mg capsules
0802040Y0BBACAC
|
Revlimid | Lenalidomide | Malignant Disease and Immunosuppression | No data available |
|
Revlimid 2.5mg capsules
0802040Y0BBAEAE
|
Revlimid | Lenalidomide | Malignant Disease and Immunosuppression | No data available |
|
Revlimid 20mg capsules
0802040Y0BBAGAG
|
Revlimid | Lenalidomide | Malignant Disease and Immunosuppression | No data available |
|
Revlimid 25mg capsules
0802040Y0BBADAD
|
Revlimid | Lenalidomide | Malignant Disease and Immunosuppression | No data available |
|
Revlimid 5mg capsules
0802040Y0BBAAAA
|
Revlimid | Lenalidomide | Malignant Disease and Immunosuppression | No data available |
|
Revlimid 7.5mg capsules
0802040Y0BBAFAF
|
Revlimid | Lenalidomide | Malignant Disease and Immunosuppression | No data available |
|
Revocon 25mg tablets
0409030C0BEAAAA
|
Revocon | Tetrabenazine | Central Nervous System | No data available |
|
Revolade 25mg tablets
0901040C0BBAAAA
|
Revolade | Eltrombopag | Nutrition and Blood | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.